Cardiac Xenotransplantation : Challenges, Evolution, and Advances
© 2022 The Authors..
The increased need for heart transplantation in patients with advanced heart failure has introduced demand for a greater supply of donor hearts. Progress in cross-species experimental models has led to promise for ushering in the clinical use of xenotransplantation (XTx) as a potential solution to the organ shortage worldwide. In this review, the authors first highlight the historical advances that led to the first pig-to-human heart transplantation, a landmark moment in the field of advanced heart failure. The authors discuss immunologic, infectious, and physiological challenges for implementation of XTx, as well as innovations in the science of genetic manipulation that allowed clinical translation of this therapy. The authors consider ongoing barriers that affect ongoing translation of this technology into clinical care in the current era. Finally, the authors propose a framework for advancing clinical application of XTx.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
---|---|
Enthalten in: |
JACC. Basic to translational science - 7(2022), 7 vom: 01. Juli, Seite 716-729 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Boulet, Jacinthe [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Revised 13.08.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.jacbts.2022.05.003 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM344774848 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM344774848 | ||
003 | DE-627 | ||
005 | 20231226023543.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jacbts.2022.05.003 |2 doi | |
028 | 5 | 2 | |a pubmed24n1149.xml |
035 | |a (DE-627)NLM344774848 | ||
035 | |a (NLM)35958689 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Boulet, Jacinthe |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cardiac Xenotransplantation |b Challenges, Evolution, and Advances |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 13.08.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2022 The Authors. | ||
520 | |a The increased need for heart transplantation in patients with advanced heart failure has introduced demand for a greater supply of donor hearts. Progress in cross-species experimental models has led to promise for ushering in the clinical use of xenotransplantation (XTx) as a potential solution to the organ shortage worldwide. In this review, the authors first highlight the historical advances that led to the first pig-to-human heart transplantation, a landmark moment in the field of advanced heart failure. The authors discuss immunologic, infectious, and physiological challenges for implementation of XTx, as well as innovations in the science of genetic manipulation that allowed clinical translation of this therapy. The authors consider ongoing barriers that affect ongoing translation of this technology into clinical care in the current era. Finally, the authors propose a framework for advancing clinical application of XTx | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a CRISPR/Cas9, clustered regularly interspaced short palindromic repeats–associated RNA-guided DNA endonuclease Cas9 | |
650 | 4 | |a GH, growth hormone | |
650 | 4 | |a Gal, α-galactose 1,3-galactose | |
650 | 4 | |a HF, heart failure | |
650 | 4 | |a HTx, heart transplantation | |
650 | 4 | |a NHP, nonhuman primate | |
650 | 4 | |a PERV, porcine endogenous retrovirus | |
650 | 4 | |a XTx, xenotransplantation | |
650 | 4 | |a cardiac transplantation | |
650 | 4 | |a gene editing | |
650 | 4 | |a xenotransplantation | |
700 | 1 | |a Cunningham, Jonathan W |e verfasserin |4 aut | |
700 | 1 | |a Mehra, Mandeep R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t JACC. Basic to translational science |d 2016 |g 7(2022), 7 vom: 01. Juli, Seite 716-729 |w (DE-627)NLM258427175 |x 2452-302X |7 nnns |
773 | 1 | 8 | |g volume:7 |g year:2022 |g number:7 |g day:01 |g month:07 |g pages:716-729 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jacbts.2022.05.003 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 7 |j 2022 |e 7 |b 01 |c 07 |h 716-729 |